Sponsors

BHR Biosynex announces UK distribution deals

Diagnostics firm BHR Biosynex has announced two exclusive distribution deals for new analyser platforms in the UK.

The first is with Hunan Ehome Health Technology for the EHBT-50 Minilab Multi-Functional Analyser, an all-in-one diagnostic platform that brings together haematology, immunology, biochemistry, urine and faecal testing in a single compact device.

For healthcare professionals, the EHBT-50 enables faster, more efficient and cost-effective workflows across hospitals, laboratories, GP practices and community settings. For patients, it translates into quicker access to accurate results, earlier diagnosis, timely treatment decisions and smoother care pathways – helping to improve both outcomes and overall healthcare system efficiency. BHR Biosynex is pleased to confirm that the EHBT-50 will launch in the UK with a fully validated NHS Hospital Protocol Template to support clinical adoption.

The second agreement is with Hangzhou AllTest Biotech for the AFR-900 Fluorescence Immunoassay Analyser (pictured above), bringing an innovative, compact point-of-care testing (POCT) solution to healthcare professionals across the UK.

The AFR-900 combines laboratory-level accuracy with true portability, making it an ideal solution for a wide range of care environments, from GP surgeries and community clinics to hospitals and ambulance services. Weighing less than 1.5 kg and equipped with a built-in battery, the analyser can be easily deployed wherever rapid, reliable results are needed.

Designed with healthcare professionals in mind, the AFR-900 delivers results in just 3–15 minutes, supporting faster clinical decision-making and improving patient flow. Its plug-and-play operation and intuitive seven-inch colour touch screen ensure ease of use with minimal training required, while seamless LIS compatibility enables straightforward data transfer. The system’s broad menu of tests covers key clinical areas including cardiac markers, inflammation, endocrinology, infectious diseases, and women’s health.

Both new products will be showcased by BHR Biosynex at IBMS Congress- 22-25 September, at stand 900, where healthcare professionals will be able to see live demonstrations and explore the capabilities of each analyser first-hand.

 

Latest Issues

IBMS Congress

The International Convention Centre (ICC), Birmingham
22-25 September, 2025

Diagnostics North East Conference 2025

The Catalyst, Newcastle
3 October

Delivering POCT: Diagnostics in the Community

Manchester Conference Centre
8 October